GL1X · GenesisL1 explorer

MolNFT v1 · #121037 · protein

Crystal structure of leishmania mexicana arginase in complex with inhibitor abhdp

5HJA: “Crystal structure of leishmania mexicana arginase in complex with inhibitor abhdp”. X-ray diffraction, 2 ligands (XA2, MN), 1 pocket (best druggability 0.39). MolNFT v1 #121037 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5HJA
Type
protein
Length
303 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arginase
EC
3.5.3.1
UniProt
Q6TUJ5
Ligands
XA2, MN
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AArginase (EC 3.5.3.1)protein30345% helix, 17% strandQ6TUJ5

Ligands and binding sites

  • XA2 · (R)-2-amino-6-borono-2-(1-(3,4-dichlorobenzyl)piperidin-4-yl)hexanoic acid · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.390.7920XA2

Compared structures

  • 5HJA · Crystal structure of Leishmania mexicana arginase in complex with inhibitor ABHDP · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.